Dextran-protamine polycation: an efficient nonviral and haemocompatible gene delivery system

Colloids and Surfaces. B, Biointerfaces
Jane Joy ThomasChandra P Sharma

Abstract

Despite the remarkable progress in the field of gene therapy with viral vectors, nonviral vectors have attracted great interests due to their unique properties. Imparting desired characteristics to nonviral gene delivery systems requires the development of cationic polymers. The purpose of this work was to design a cationic derivative (Dex-P) of dextran using protamine in order to assert target specific cellular binding. Our objective was to elucidate the potential use of Dex-P as a haemocompatible, nontoxic and efficient nonviral candidate for gene therapy. Nanoplexes were prepared with calf thymus DNA and Dex-P. Derivatization was confirmed by FTIR, gel permeation chromatography and TNBS assay. Dynamic light scattering and TEM studies determined the size and morphology of the nanoplex. The buffering behaviour was assessed by acid base titration. Complexation stability was evaluated using agarose gel electrophoresis and EtBr displacement assay. The protection of ctDNA from nuclear digestion and the effect of plasma components towards stability of the nanoplexes were also analyzed. Various haemocompatible studies were performed to check haemolysis, aggregation, clotting time, and complement activation. Transfection and cytotoxi...Continue Reading

References

Mar 11, 1992·Nucleic Acids Research·E BrunetteR Debs
Aug 1, 1965·Journal of Molecular Biology·M J Waring
Feb 12, 1998·Gene Therapy·F L SorgiL Huang
Apr 6, 2000·Pharmaceutical Research·S C De SmedtW E Hennink
Nov 30, 2000·The Journal of Peptide Research : Official Journal of the American Peptide Society·D J MitchellJ B Rothbard
Nov 22, 2001·Bioconjugate Chemistry·S FutakiY Sugiura
Dec 18, 2001·Advanced Drug Delivery Reviews·R KircheisE Wagner
Apr 19, 2002·Journal of Medicinal Chemistry·Tony AzzamAbraham J Domb
Mar 12, 2003·Journal of Controlled Release : Official Journal of the Controlled Release Society·Hossein HosseinkhaniYasuhiko Tabata
Sep 10, 2003·Biomacromolecules·Wen-Chi Tseng, Chai-Min Jong
Sep 18, 2003·Bioconjugate Chemistry·M Laird ForrestDaniel W Pack
Mar 17, 2004·Proceedings of the National Academy of Sciences of the United States of America·John D LewisJuan Ausió
Aug 5, 2004·The Journal of Gene Medicine·Wen-Chi TsengTsuei-Yun Fang
Nov 16, 2004·The Journal of Gene Medicine·Akin AkincRobert Langer
Mar 12, 2005·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Dirk LochmannAndreas Zimmer
Sep 6, 2005·Biochemical and Biophysical Research Communications·Jun Feng LiangYekaterina Vaynshteyn
Aug 11, 2007·International Journal of Pharmaceutics·Benoît VromanVéronique Préat
Oct 24, 2007·Biomaterials·Mitsuaki TodaHiroo Iwata
Nov 17, 2007·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·H EliyahuA J Domb
Jul 1, 2008·Journal of Controlled Release : Official Journal of the Controlled Release Society·Julia M Martínez GómezPål Johansen
Aug 12, 2008·Journal of Controlled Release : Official Journal of the Controlled Release Society·Suna Choi, Kyung-Dall Lee
Jun 9, 2009·International Journal of Pharmaceutics·Latha AravindanAdrian C Williams

❮ Previous
Next ❯

Citations

May 11, 2011·International Journal of Nanomedicine·Yachun LiuJian Zhang
May 18, 2013·Advanced Drug Delivery Reviews·Koen RaemdonckStefaan C De Smedt
Jan 17, 2012·Expert Opinion on Drug Delivery·José Vicente González-AramundizNoemi Csaba
Oct 2, 2012·Acta Biomaterialia·Wahid KhanAbraham J Domb
Jun 19, 2012·Biomaterials·Cherukaraveedu V DurgadasChandra P Sharma
Mar 22, 2016·Expert Opinion on Biological Therapy·Ahad MokhtarzadehMohammad Ramezani
Sep 27, 2014·Carbohydrate Polymers·Sofia OchrimenkoDagmar Fischer
Apr 24, 2016·International Journal of Pharmaceutics·Zhaoyan ZengLi Zong
Jun 27, 2019·Macromolecular Bioscience·Matthias ZinkDagmar Fischer

❮ Previous
Next ❯

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.

Bacterial Cell Wall Structure

Bacterial cell walls are made of peptidoglycan (also called murein), which is made from polysaccharide chains cross-linked by unusual peptides containing D-amino acids. Here is the latest research on bacterial cell wall structures.

Bacterial Cell Wall Structure (ASM)

Bacterial cell walls are made of peptidoglycan (also called murein), which is made from polysaccharide chains cross-linked by unusual peptides containing D-amino acids. Here is the latest research on bacterial cell wall structures.